পদ্ধতির তুলনা করুন

	পেডমিডাস: পেডিয়াট্রিক মাইগ্রেন ডিসএবিলিটি অ্যাসেসমেন্ট স্কেল	শিশুদের হাঁপানি জীবনযাত্রার মান প্রশ্নাবলী (PAQLQ)	শৈশবে মৃগীরোগে জীবনযাত্রার মান (QOLCE)
ক্ষেত্র	শিশু চিকিৎসা	শিশু চিকিৎসা	শিশু চিকিৎসা
পরিবার	Process / pipeline	Process / pipeline	Process / pipeline
উদ্ভবের বছর	2001	1996	2000
প্রবর্তক	Amy D. Hershey	E. F. Juniper	Mark Sabaz
ধরন	Parent-report and/or child self-report of missed activities	Child self-report; parent version available	Parent report; child self-report version available
মৌলিক উৎস	Hershey, A. D., Powers, S. W., Vockell, A. L., LeCates, S., & Ellinwood, E. H. (2001). PedMIDAS: Development of a questionnaire to assess disabilities in migrainous children. Headache, 41(6), 556-563.	Juniper, E. F., Guyatt, G. H., Feeny, D. H., Ferrie, P. J., Griffith, L. E., & Townsend, M. (1996). Measuring quality of life in children with asthma. Quality of Life Research, 5(1), 35-46.	Sabaz, M., Cairns, D. R., Lah, S., Williams, B., Gurrin, L., Connelly, A., & Berkovic, S. F. (2000). Validation of the Quality of Life in Childhood Epilepsy Questionnaire in Australian children with newly diagnosed and chronic epilepsy. Neurology, 55(9), 1646-1652.
অপর নাম	Pediatric Migraine Disability Assessment, MIDAS, MIDAS Pediatric	PAQLQ-S	QOL in Childhood Epilepsy Questionnaire
সম্পর্কিত	4	4	4
সারসংক্ষেপ	The PedMIDAS is a brief 6-item parent-report (with child input for older youth) instrument developed by Hershey et al. in 2001 to quantify migraine-related functional disability in children and adolescents. Rather than measuring pain intensity or headache frequency, the PedMIDAS focuses on the ultimate impact of migraine on daily life: how many days of school, sports/play, and family activities does the child miss or participate in only with significant limitation? This outcome-focused approach makes it particularly useful for assessing the real-world burden of migraine in children and evaluating treatment effectiveness.	The PAQLQ is a 23-item self-report instrument developed by Juniper et al. in 1996 to measure quality of life in children aged 7–17 years with asthma. It assesses how asthma and its treatment affect daily functioning, emotions, and activity levels. The instrument has become the gold standard for evaluating asthma-specific health-related quality of life in pediatric populations.	The QOLCE is a comprehensive 76-item disease-specific instrument developed by Sabaz et al. in 2000 to assess quality of life in children with epilepsy aged 4–16 years. Measuring across 16 distinct domains including seizure worry, cognitive concerns, medication effects, school/peer functioning, and family impact, the QOLCE provides a nuanced profile of how epilepsy and its treatment affect daily life. It exists in parent-report (QOLCE-P) and child self-report (QOLCE-C) versions.